Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.10B | 2.33B | 2.30B | 1.46B | 1.02B |
Gross Profit | 71.64M | 148.80M | 285.51M | 142.80M | 91.41M |
EBITDA | 77.03M | 163.47M | 266.82M | 176.34M | 113.14M |
Net Income | -16.04M | 54.92M | 121.38M | 59.14M | 24.48M |
Balance Sheet | |||||
Total Assets | 1.68B | 1.66B | 1.06B | 971.94M | 969.90M |
Cash, Cash Equivalents and Short-Term Investments | 352.62M | 300.71M | 106.16M | 73.03M | 78.34M |
Total Debt | 338.27M | 262.97M | 219.16M | 96.89M | 125.83M |
Total Liabilities | 584.85M | 535.95M | 334.98M | 400.14M | 447.76M |
Stockholders Equity | 985.37M | 1.02B | 573.79M | 457.93M | 400.56M |
Cash Flow | |||||
Free Cash Flow | 13.82M | -43.95M | 199.74M | 44.27M | -21.69M |
Operating Cash Flow | 96.86M | 104.46M | 318.82M | 94.88M | 50.62M |
Investing Cash Flow | -268.86M | -71.06M | -150.12M | -59.21M | -72.31M |
Financing Cash Flow | 2.49M | 204.95M | -133.45M | -40.95M | 20.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $945.36M | 9.80 | 2.51% | 8.33% | -1.70% | 12.53% | |
68 Neutral | HK$225.60M | 14.87 | 6.12% | 2.22% | -4.13% | -35.11% | |
61 Neutral | 7.33 | -1.60% | 4.22% | 30.77% | -128.09% | ||
57 Neutral | HK$696.28M | ― | -8.95% | ― | -3.09% | -480.17% | |
56 Neutral | $6.41B | 9.61 | -29.56% | 6.32% | 10.97% | -32.97% | |
49 Neutral | HK$763.30M | 55.38 | -1.16% | 7.63% | 2.49% | -171.78% | |
48 Neutral | HK$72.62M | ― | ― | -60.57% | 53.71% |
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced the successful approval of all resolutions at its annual general meeting held on May 21, 2025. The resolutions included the approval of the company’s financial reports, profit distribution plan, and the appointment of Deloitte Touche Tohmatsu as auditors. Notably, the company decided not to distribute a final dividend for the year ended December 31, 2024, which may impact shareholder returns.